Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.39 HKD | +2.92% | +23.99% | +10.63% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |